About 3 400 reports

  • NAPABUCASIN'S CLINICAL DEVELOPMENT IN CRC
  • TECENTRIQ'S CLINICAL DEVELOPMENT IN CRC
  • Pharmaceutical
  • Company
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • CHF-5993 (BECLOMETHASONE DIPROPIONATE + FORMOTEROL FUMARATE + GLYCOPYRROLATE)
  • COMPANY PORTFOLIO GAP ANALYSIS IN COPD, 2015-2025

IN OCTOBER 2009, SEPRACOR WAS ACQUIRED BY DAINIPPON SUMITOMO PHARMA, AN OSAKA, JAPAN-BASED PHARMACEUTICAL COMPANY.

  • Pharmaceutical
  • Company
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • Current and Future Players
  • KEY COMPANIES IN THE SLE AND LN MARKET IN THE 7MM, 2016

ANTHERA PHARMACEUTICALS (2015).

  • Pharmaceutical
  • World
  • Company
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Aurobindo Pharma Ltd. Revenue by Geography
  • companies. Generic pharmaceutical firms accounted for 6% of Recipharm"s sale share in 2014.
  • Pharmaceutical
  • World
  • Company
  • Aurobindo Pharma Limited
  • Catalent Pharma Solutions, Inc.
  • PRODUCT PROFILE - IBRANCE
  • PRODUCT PROFILE - MARGETUXIMAB

OBI Pharma (2016).

  • Pharmaceutical
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • PRODUCT PROFILE - QUADRIVALENT SEASONAL INFLUENZA VLP VACCINE
  • SALES FORECASTS ($M) FOR SEASONAL INFLUENZA VACCINES IN GERMANY, 2015 -2025

MITSUBISHI TANABE PHARMA (2016).

  • Pharmaceutical
  • Europe
  • Company
  • CSL Limited
  • Daiichi Sankyo Company
  • OTHER PRODUCTS IN CLINICAL DEVELOPMENT FOR HCV INFECTION, 2016
  • CLINICAL DEVELOPMENT OUTSIDE 9MM, 2016

TOKYO, JAPAN: CHUGAI PHARMACEUTICAL.

  • Pharmaceutical
  • Company
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • POST-HSCT EFFICACY ANALYSIS OF THE PHASE III TRIAL (CELATOR, NCT01696084) OF VYXEOS IN
  • EFFICACY OF VYXEOS VERSUS 7+3 IN THE PHASE III TRIAL (CELATOR, NCT01696084)

MEI PHARMA (2016).

  • Pharmaceutical
  • Company
  • Astellas Pharma Inc.
  • Celgene Corporation
  • Novartis AG
  • OTHER LOCATIONS & SUBSIDIARIES
  • EMS SA, History

The company' s deal volume decreased from five pharmaceuticals & healthcare deals in 2015 to two pharmaceuticals & healthcare deals in 2016.

  • Pharmaceutical
  • Brazil
  • Company
  • GlaxoSmithKline plc
  • GlobalData's company
  • NOVARTIS' NSCLC PORTFOLIO ASSESSMENT, 2016
  • BMS SWOT ANALYSIS IN NSCLC, 2016

ASTELLAS PHARMA (2016).

  • Pharmaceutical
  • Company
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • AVELUMAB'S DEVELOPMENT IN RCC
  • AVEO ONCOLOGY'S RCC PORTFOLIO ASSESSMENT, 2016
  • Pharmaceutical
  • Company
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • PRODUCT PROFILE - REMICADE
  • KEY COMPANIES IN THE PSORIASIS MARKET, 2015

LEO PHARMA (2015).

  • Pharmaceutical
  • World
  • Company
  • Amgen Inc.
  • Merck & Co., Inc.
  • OTHER DRUGS IN PHASE II OF CLINICAL DEVELOPMENT FOR HIV, 2016
  • VIIV'S DOLUTEGRAVIR/LAMIVUDINE - PHASE III CLINICAL TRIALS

TITUSVILLE, NEW JERSEY, US: JANSSEN PHARMACEUTICALS; 2016.

  • Pharmaceutical
  • Asia
  • Japan
  • Company
  • Gilead Sciences, Inc.
  • 6.3 COMPANY PROFILES
  • SWOT ANALYSIS - ROCHE

IN THE MOST COMMON MODEL, A PHARMACEUTICAL COMPANY FORMS A PARTNERSHIP WITH A DIAGNOSTIC TEST COMPANY.

  • Pharmaceutical
  • Company
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • bioMerieux S.A.
  • AGENTS IN PHASE I OR EARLY PHASE II CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B
  • OTHER AGENTS IN CLINICAL DEVELOPMENT FOR CHRONIC HEPATITIS B TREATMENT, 2015

TETRALOGIC PHARMACEUTICALS (2015).

  • Pharmaceutical
  • Company
  • Gilead Sciences, Inc.
  • Novartis AG
  • Roche Group

The agreement allows TT-## to be co-marketed by Teijin Pharma Limited, the core company of the Teijin Group' s medical and pharmaceutical business, and Taisho Toyama Pharmaceutical Co., Ltd. of the Taisho Pharmaceutical Group.

  • Pharmaceutical
  • Asia
  • China
  • Company
  • Bayer AG
  • SUMMARY OF RESULTS FROM A PHASE II TRIAL OF ABRAXANE
  • SUMMARY OF AES FROM THE PHASE II TRIAL OF NIMOTUZUMAB IN COMBINATION WITH IRINOTECAN

PHARMA JAPAN WEB.

  • Pharmaceutical
  • Company
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • TETRAPHASE PHARMACEUTICALS INC. N/A
  • COMPANY PORTFOLIO GAP ANALYSIS FOR HAIS AGAINST GRAM-NEGATIVE BACTERIA, 2016-2026
  • Anti-Infective
  • Hospital
  • Pharmaceutical
  • Therapy
  • Company
  • 4.3 ANTARES PHARMA INC
  • 4.2.1 Company Overview
  • Pharmaceutical
  • France
  • Company
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc.
  • 4.3 ANTARES PHARMA INC
  • 4.2.1 Company Overview
  • Pharmaceutical
  • Italy
  • Company
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc.
  • Company Name: F. Hoffmann-La Roche AG Address: Konzern Hauptsitz

Genentech, Chugai, and Roche Pharmaceuticals comprise the Roche Group' s Pharmaceuticals Division.

  • Pharmaceutical
  • Company
  • DexCom, Inc.
  • Medtronic, Inc.
  • Roche Group
  • Acquisitions of Valeant Pharmaceuticals
  • 6. Company Profiling
  • Pharmaceutical
  • United States
  • Company
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • 6.3 Orion Corporation
  • ORION CORPORATION NET SALES BY SEGMENTS; 2016

On February ##, 2016 Swiss pharmaceutical company Primex Pharmaceuticals AG and French pharmaceutical laboratory Advicenne SA announced that Primex acquired global rights for an advanced oral pharmaceutical candidate for pediatric anesthesiology developed by Advic

  • Pharmaceutical
  • Europe
  • Company
  • Demand
  • Aspen Pharmacare Holdings Limited
  • Product Profile - Remicade
  • presents the global sales forecasts for Otezla during 2014-2024.

LEO Pharma (2015).

  • Pharmaceutical
  • Company
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Product Profile - Remicade
  • Global Sales Forecast ($m) for Otezla, 2014-2024

LEO Pharma (2015).

  • Pharmaceutical
  • Company
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MERCK AND CO. RESEARCH AND DEVELOPMENT EXPENDITURE (2010-2014)
  • 6.4.3 Business Strategies

The Pharmaceuticals segment consists of three sub segments, namely, Roche Pharma, Genentech, and Chugai.

  • Pharmaceutical
  • World
  • Company
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Product Profile - Remicade
  • presents the global sales forecasts for Otezla during 2014-2024.

LEO Pharma (2015).

  • Pharmaceutical
  • Company
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Product Profile - Remicade
  • Global Sales Forecast ($m) for Otezla, 2014-2024

LEO Pharma (2015).

  • Pharmaceutical
  • Company
  • Amgen Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 7.1 GALENICA GROUP
  • Galenica's Net Sales Share by Region (2016)

Vifor Pharma is an international specialty pharma company that researches, develops, produces and markets its own pharmaceutical products.

  • Pharmaceutical
  • Company
  • Allergan plc
  • AMAG Pharmaceuticals, Inc.
  • Galenica Group
  • CMO Acquisitions of Bio/Pharmaceutical Company Facilities 2015
  • CMO Acquisitions of Bio/Pharmaceutical Company Facilities 2016
  • Pharmaceutical
  • World
  • Company
  • Market Size
  • Catalent Pharma Solutions, Inc.